Observed facts: The source says the researcher and agent searched UniProt for antimicrobial peptide candidates in Streptococcus pseudopneumoniae, with ProtNLM helping identify functional candidates among sequences. It describes sequence novelty checks, AlphaFold structure retrieval and comparison, inspection of neighboring genes, and literature synthesis. The reported 97-amino-acid candidate has structural and genomic-context support, and is undergoing wet-lab validation alongside other candidates.
Mechanism: The workflow reduces fragmented triage by combining database queries, structural inspection, genomic-context reasoning, literature review, and experimental planning in a shared session; the researcher sets goals and steers analysis while the agent coordinates computational steps. Why now: The source says large sequence repositories contain many uncharacterized proteins and researchers need ways to prioritize them; the candidate and others are already entering wet-lab validation.
Implication: The near-term value is a shorter path from broad sequence search to a prioritized, testable lab hypothesis, not autonomous therapeutic discovery. Evidence boundary: The evidence is a company-authored technical walkthrough reporting computational support for a candidate; it does not report wet-lab results establishing antimicrobial activity, safety, or clinical usefulness.
Watch condition: The decisive next evidence is whether wet-lab validation confirms activity and acceptable toxicity for this candidate. More broadly, useful evaluation would show whether this integrated workflow reproducibly improves candidate prioritization versus established bioinformatics practice. The source provides no comparative performance measurement or independent validation.